Biofarm și-a redus profitul cu 46% în primul semestru, în perioada în care compania a fost preluată de grupul polonez Polpharma

Biofarm reported a net profit of 26.4 million lei in the first half of 2026, down 45.9% from 2025. The company experienced a decline in sales revenue and significant increases in personnel costs. Following its acquisition by ZF Polpharma, Biofarm aims to expand its market presence and invest in development.